These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24372487)

  • 1. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
    Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
    Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
    Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
    Int J Gynecol Cancer; 2024 Jul; 34(7):1027-1033. PubMed ID: 38658016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
    Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
    J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to differentiate benign from malignant myometrial tumours using MR imaging.
    Thomassin-Naggara I; Dechoux S; Bonneau C; Morel A; Rouzier R; Carette MF; Daraï E; Bazot M
    Eur Radiol; 2013 Aug; 23(8):2306-14. PubMed ID: 23563602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine smooth muscle tumours with hyperintense area on T
    Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
    Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
    Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
    Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
    Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging characteristics of uterine smooth muscle tumors of uncertain malignant potential: a case report and literature review.
    Liu S; Chang J; Su W; Lv H; Xu B; Gong W
    J Int Med Res; 2024 Sep; 52(9):3000605241279183. PubMed ID: 39344823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI appearance of mesenchymal tumors of the uterus.
    Cornfeld D; Israel G; Martel M; Weinreb J; Schwartz P; McCarthy S
    Eur J Radiol; 2010 Apr; 74(1):241-9. PubMed ID: 19349135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density.
    Tasaki A; Asatani MO; Umezu H; Kashima K; Enomoto T; Yoshimura N; Aoyama H
    Abdom Imaging; 2015 Aug; 40(6):1742-52. PubMed ID: 25526683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative ultrasound-guided needle biopsy of 63 uterine tumors having high signal intensity upon T2-weighted magnetic resonance imaging.
    Tamura R; Kashima K; Asatani M; Nishino K; Nishikawa N; Sekine M; Serikawa T; Enomoto T
    Int J Gynecol Cancer; 2014 Jul; 24(6):1042-7. PubMed ID: 24927248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
    Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
    Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
    Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
    Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
    Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
    Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of uterine cotyledonoid dissecting leiomyoma with adenomyosis.
    Shimizu A; Tanaka H; Iwasaki S; Wakui Y; Ikeda H; Suzuki A
    Diagn Pathol; 2016 Aug; 11(1):69. PubMed ID: 27491369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
    Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
    J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.